These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31172266)

  • 41. Benefit of Biological Drugs for Quality of Life in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Clinical Trials.
    Tański W; Świątoniowska-Lonc N; Dudek K; Jankowska-Polańska B
    Adv Exp Med Biol; 2021; 1335():63-78. PubMed ID: 33378002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study.
    Burgos-Varga R; Wei JC; Rahman MU; Akkoc N; Haq SA; Hammoudeh M; Mahgoub E; Singh E; Llamado LJ; Shirazy K; Kotak S; Hammond C; Pedersen R; Shen Q; Vlahos B
    Arthritis Res Ther; 2016 Jun; 18(1):132. PubMed ID: 27267875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: Results from a nationwide study.
    Ziade N; Abi Karam G; Merheb G; Mallak I; Irani L; Alam E; Messaykeh J; Menassa J; Mroue' K; Uthman I; Masri AF; Ghorra P; Witte T; Baraliakos X
    Int J Rheum Dis; 2019 Apr; 22(4):708-714. PubMed ID: 30729696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-B27 is associated with reduced disease activity in axial spondyloarthritis.
    Rosenbaum JT; Weisman MH; Hamilton H; Shafer C; Aslanyan E; Howard RA; Ogle K; Reveille JD; Winthrop KL; Choi D
    Sci Rep; 2021 Jun; 11(1):12331. PubMed ID: 34112886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1,492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE)].
    da Costa IP; Bortoluzzo AB; Gonçalves CR; da Silva JA; Ximenes AC; Bértolo MB; Ribeiro SL; Keiserman M; Menin R; Skare TL; Carneiro S; Azevedo VF; Vieira WP; Albuquerque EN; Bianchi WA; Bonfiglioli R; Campanholo C; Carvalho HM; Duarte AL; Kohem CL; Leite NH; Lima SA; Meirelles ES; Pereira IA; Pinheiro MM; Polito E; Resende GG; Rocha FA; Santiago MB; Sauma Mde F; Valim V; Sampaio-Barros PD
    Rev Bras Reumatol; 2015; 55(1):48-54. PubMed ID: 25542672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study.
    Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
    Ann Rheum Dis; 2012 Jul; 71(7):1207-11. PubMed ID: 22523430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimizing the identification of patients with axial spondyloarthritis in primary care--the case for a two-step strategy combining the most relevant clinical items with HLA B27.
    Braun A; Gnann H; Saracbasi E; Grifka J; Kiltz U; Letschert K; Braun J
    Rheumatology (Oxford); 2013 Aug; 52(8):1418-24. PubMed ID: 23559574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real-world study.
    Korotaeva T; Dina O; Holdsworth E; Fallon L; Milligan G; Meakin S; Wang L; Vasilescu R; Cappelleri JC; Deodhar A
    Clin Rheumatol; 2021 Dec; 40(12):4915-4926. PubMed ID: 34319479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action.
    Rodrigues-Manica S; Silva J; Cruz-Machado R; Coelho C; Duarte J; Vieira-Sousa E; Tavares-Costa J; Pimentel-Santos FM
    Clin Rheumatol; 2021 Jan; 40(1):33-41. PubMed ID: 32533340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia.
    Omair MA; AlDuraibi FK; Bedaiwi MK; Abdulaziz S; Husain W; El Dessougi M; Alhumaidan H; Al Khabbaz HJ; Alahmadi I; Omair MA; Al Saleh S; Alismael K; Al Awwami M
    Clin Rheumatol; 2017 Jul; 36(7):1537-1543. PubMed ID: 28456926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).
    Madsen OR
    Rheumatol Int; 2018 Mar; 38(3):425-432. PubMed ID: 29299630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis.
    Baraliakos X; Baerlecken N; Witte T; Heldmann F; Braun J
    Ann Rheum Dis; 2014 Jun; 73(6):1079-82. PubMed ID: 23644552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy.
    Maguire S; Wilson F; Gallagher P; O'Shea FD
    Scand J Rheumatol; 2023 Mar; 52(2):142-149. PubMed ID: 35048786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Widespread pain in axial spondyloarthritis: clinical importance and gender differences.
    Swinnen TW; Westhovens R; Dankaerts W; de Vlam K
    Arthritis Res Ther; 2018 Jul; 20(1):156. PubMed ID: 30053895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation and cultural adaptation of the qualisex questionnaire in patients with axial spondyloarthritis in Argentina.
    Sommerfleck FA; Schneeberger EE; Orozco MC; Zamora N; Landi M; Citera G
    Rheumatol Int; 2018 Nov; 38(11):2103-2109. PubMed ID: 30167765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extra-articular manifestations and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis.
    Erol K; Gok K; Cengiz G; Kilic G; Kilic E; Ozgocmen S
    Acta Reumatol Port; 2018; 43(1):32-39. PubMed ID: 29342471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY; Jung JY; Hong YS; Ju JH; Park SH
    Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic value of anti-CD74 antibodies in early and late axial spondyloarthritis and its relationship to disease activity.
    Abdelaziz MM; Gamal RM; Ismail NM; Lafy RA; Hetta HF
    Rheumatology (Oxford); 2021 Jan; 60(1):263-268. PubMed ID: 32710117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project. German version].
    Callhoff J; Albrecht K; Hoffmann F; Poddubnyy D; Günther KP; Zink A
    Z Rheumatol; 2019 Oct; 78(8):713-721. PubMed ID: 31273459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Axial spondyloarthritis criteria and modified NY criteria: issues and controversies.
    Deodhar A
    Clin Rheumatol; 2014 Jun; 33(6):741-7. PubMed ID: 24838363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.